NEWS

What are you interested in?

All topics
Arts
Social Sciences
Life Sciences
Medicine
Management
Engineering
Law
Humanities
General
Exact Sciences
Environment

Research

Feb 11th, 2025
Is the Spread of Deadly Pathogens Threatening Coral Reefs Worldwide?

From Eilat to the Indian Ocean, a relentless pathogen is ravaging marine ecosystems

  • Life Sciences

An international team of researchers, led by scientists from Tel Aviv University, has discovered that the pathogen responsible for the mass deaths of sea urchins along the Red Sea coast is the same one responsible for mass mortality events among sea urchins off the coast of Réunion Island in the Indian Ocean. This finding raises fears that the pathogen – a waterborne ciliate - could spread further, to the Pacific Ocean. The researchers warn that this is a highly aggressive global pandemic, and are now spearheading an international effort to track the disease and preserve sea urchins, which play a crucial role in the health of coral reefs.

 

The study, led by Dr. Omri Bronstein from the School of Zoology at Tel Aviv University’s Wise Faculty of Life Sciences and the Steinhardt Museum of Natural History, was published in the prestigious journal Ecology.

 

The Research Team. Photo credit: Tel Aviv University.

 

“This is a first-rate ecological disaster”, explains Dr. Bronstein.

 

She continues: “Sea urchins are vital to the health of coral reefs. They act as the ‘gardeners’ of the reef by feeding on algae, preventing it from overgrowing and suffocating the coral, which competes with algae for sunlight. In 1983, a mysterious disease wiped out most of the Diadema sea urchins in the Caribbean. Unchecked, the algae there proliferated, blocking sunlight from the coral, and the region shifted from a coral reef ecosystem to an algae-dominated one. Even 40 years later, the sea urchin population — and consequently the reef — has not recovered”.

 

In 2022, the disease reemerged in the Caribbean, targeting the surviving sea urchin populations and individuals. This time, armed with advanced scientific and technological tools to collect and interpret the forensic evidence, researchers at Cornell University successfully identified the pathogen as a ciliate Scuticociliate parasite. A year later, in early 2023, Dr. Bronstein was the first to identify mass mortality events among long-spined sea urchins, a close relative of the Caribbean Sea urchins, in the Red Sea.

 

Sea urchin mortalities on Reunion Island. Photo credit: Jean-Pascal Quod.

 

“Until recently, this was one of the most common sea urchins in Eilat’s coral reefs — the familiar black urchins with long spines,” says Dr. Bronstein. “Today, this species no longer exists in significant numbers in the Red Sea. The event was extremely violent: within less than 48 hours, a healthy population of sea urchins turned into crumbling skeletons. In some locations in Eilat and the Sinai, mortality rates reached 100 percent. In follow-up research, we demonstrated that the Caribbean pathogen was the same one affecting populations in the Red Sea”.

 

Genetic Proof Links Global Sea Urchin Deaths to One Pathogen

Now, using genetic tools, Dr. Bronstein and his international colleagues have shown that the same ciliate parasite is responsible for similar mortality events off the coast of Réunion Island in the Indian Ocean. “This is the first genetic confirmation that the same pathogen is present in all these locations,” he says. “Now it’s a global event, a pandemic. The Caribbean, Red Sea, and the Indian Ocean are critical regions for the world’s coral reefs, and mortality rates for sea urchins in these areas are very high — over 90 percent. As of now, we have no evidence of this pathogen in Pacific Ocean sea urchins, but this is something we are actively investigating. Although we’ve developed genetic tools for the specific identification of the pathogen, it’s difficult to monitor such rapid extinction events in the vast underwater environment. We are terrestrial creatures, and some reefs are located in deep or remote areas. If we miss the mortality event by even a couple of days, we might find no trace of the extinct population”.

 

 Four healthy sea urchin species on Reunion Island. Photo credit: Jean-Pascal Quod.

 

To track the progression of the pandemic, Dr. Bronstein has established an international network of collaborators. He provides them with alerts about the likelihood of mortality events in their regions and sends them the necessary equipment to sample and preserve affected sea urchins for comparison with samples from other locations. These kits are then sent back to the laboratory at Tel Aviv University.

 

“For populations that are already infected, we really have no tools to help them,” says Dr. Bronstein with regret. “There is no Pfizer or Moderna for sea urchins — not because we don’t want one, but because we simply can’t treat them underwater. Our focus must be on two entirely different tracks. The first is prevention. To prevent further spread of the pandemic, we need to understand why it erupted here and now. We’ve developed two hypotheses for this. The first is the transportation hypothesis — that the pathogen from the Caribbean was transported by humans to new and distant regions after being carried in the ballast water of ships, infecting sea urchins in the Red Sea before spreading to the Western Indian Ocean.

 

The sea urchin Diadema setosum before (left) and after (right) mortality. The white skeleton is exposed following tissue disintegration and loss of spines. Photo credit: Tel Aviv University.

 

How climate change might be spreading marine diseases worldwide

Incidentally, if this hypothesis is correct, we would expect to see mortality events in West Africa as well — as many cargo ships from the Caribbean stop there on their way to the Mediterranean and then through the Suez Canal to the Red Sea. Indeed, just in the past few weeks, we’ve discovered widespread mortality events in West Africa, as we predicted, and we’ve managed to obtain a limited number of samples collected during these events, which we are currently analyzing in the lab. If ships are indeed the source of the spread, then we could think of mitigation strategies. It’s not simple, and ships will never be completely sterile, but there are measures we can take. The second possibility is even more concerning: that the pathogen has always been present, and climatic changes have triggered its virulence and outbreak. That’s a challenge of an entirely different magnitude, one that we, as marine biologists, have very limited means to address”.

 

In parallel with global efforts, Dr. Bronstein has recently established a breeding nucleus for the affected sea urchins at the Israel Aquarium in Jerusalem, in collaboration with the Biblical Zoo and the Israel Nature and Parks Authority. This breeding population will serve as a reserve to restore affected populations and advance research into infection mechanisms and possible treatments.

 

“The pathogen is transmitted through water, so even sea urchins raised for research purposes in aquariums at the Interuniversity Institute for Marine Sciences and the Underwater Observatory in Eilat became infected and died. That is why we established a breeding nucleus with the Israel Aquarium, whose aquariums are completely disconnected from seawater. We genetically test the urchins transferred to the nucleus to ensure they are not carriers of the disease and that they genetically belong to the Red Sea population, enabling us to rehabilitate the population in the future. At the same time, we are using them to develop sensitive genetic tools for early disease detection from seawater samples — essentially creating ‘underwater COVID tests’ for sea urchins”.

 

 

Research

Feb 9th, 2025
When Marine Animals Become 'Plastic Distributors'

Marine animals eat and release microplastics, harming the environment.

  • Environment

A new Tel Aviv University study has uncovered alarming findings about the spread of microplastic particles in the marine food web. In recent years, numerous studies have examined the dangers of aquatic animals and more specifically, filter-feeding organisms, ingesting non-degradable microplastic particles. In the current study, the research team sought to understand how the biological filtration by filter-feeding organisms affects the microplastics in their environment. The findings indicate that the particles are excreted in the feces of marine animals, causing them to be unidentifiable as plastic to the aquatic environment, but potentially as other organic matter suitable for consumption.

 

Additionally, the presence of microplastic within feces affects the feces dispersal which causes accumulation of feces and plastic particles. This may increase carbon and nitrogen levels on the seafloor and lead to algal blooms, which have a critical impact on the balance of the marine food web.

 

The research was conducted by PhD student Eden Harel of the School of Zoology in the Wise Faculty of Life Sciences, Prof. Noa Shenkar of the School of Zoologyand the Steinhardt Museum of Natural History, and Prof. Ines Zucker of the School of Mechanical Engineering and the Porter School of Environment and Earth Sciences, all at Tel Aviv University. The study was published in the journal Chemosphere.

 

פרופ' נועה שנקר וחברים ימיים

 Prof. Shenkar during a research dive (Photo creditDr. Tom Shlesinger).

 

Prof. Shenkar explains: “About a decade ago, when awareness of the plastic pollution problem in the marine environment began to grow, many researchers focused on identifying the location and scale of microplastic particles. Recently, the research focus has shifted to the effects and damage caused by microplastics. However, many experiments in this field are conducted using clean, purchased plastic, whereas in the sea, plastic particles are exposed to a wide range of influences and pollutants. We aimed to examine whether and how plastic changes after passing through the digestive system of a marine organism and how this process affects the presence of plastic and its availability to other organisms”.

 

How Marine Organisms Process Microplastics

The researchers created an experimental system in the lab simulating seawater containing ascidians — marine animals that feed by efficiently and indiscriminately filtering tiny particles from the water. They exposed the ascidians to two types of plastic particles: conventional polystyrene (PS), which is widely used, and polylactic acid (PLA), marketed as a biodegradable, environmentally friendly bioplastic. They then examined the impact of the ascidians’ filtration process on the concentration and distribution of plastic particles in the water at four intervals: at the time of exposure, after two hours (when the ascidians had filtered all available water and ingested the microplastic particles), after 24 hours, and after 48 hours (following digestion and the excretion of feces into the water).

 

איצטלנים במעבדה (צילום: עדן הראל)

The laboratory at Tel Aviv University where the experiment was conducted (Photo creditEden Harel).

 

The findings showed that approximately 90% of the polystyrene particles were removed from the water after two hours of filtration, but all the particles returned to the water after 48 hours, following passage through the digestive system. In contrast, the concentration of PLA particles in the water significantly decreased and remained low for 48 hours, larger PLA particles likely broke down during digestion and returned to the water as smaller undetectable nano-sized particles.

 

In the second phase of the study, the researchers examined what had happened to the microplastic particles that were filtered, digested, and excreted back into the water column. To do so, they isolated microplastic particles from the ascidians’ feces and analyzed them using Raman spectroscopy, an advanced device that identifies the chemical composition of materials by scattering a laser beam.

 

Eden Harel explains: “We found that the sensitive spectroscopy device could not identify the material as plastic at all and instead identified the particle as another type of organic material. Our findings revealed that microplastic particles are excreted from the ascidian’s digestive system coated with a fecal layer, and it is likely that the marine environment also identifies these particles as this organic material. Since many marine animals feed on feces, they may well ingest plastic that has changed its properties, identifying it as food. In this way, they are also exposed to microplastics and spread them further within the marine food web. The fecal coating may serve as a substrate for bacterial colonization and increase the adhesion and accumulation of pollutants such as heavy metals and residual organic substances (like antibiotics) on the plastic particles”.

 

Prof. Zucker adds: "This phenomenon also affects bioplastics marketed as 'biodegradable': unless conditions are met for their complete breakdown, they remain as particle pollution that changes properties during passage through the digestive system. The many transformations plastic particles undergo in the environment — from weathering to digestive processes, as investigated in this study — turn them into carriers of pollutants and diseases within the food web”.

 

עדן הראל דוגמת בים (צילום: עדן הראל)

 The researchers analyzing the secretions of marine animals (Photo creditEden Harel).

 

What’s the Impact of Microplastics on Marine Life?

In the third phase of the study, the researchers examined the reverse effect: how microplastic particles affect feces, an organic material that plays a vital role in marine ecology. Eden Harel explains: “We found that plastic changes important physical properties of feces. Normal feces sink very slowly through the water column, serving as food for many organisms along the way. In contrast, feces containing microplastic particles sink rapidly to the seafloor. This removes an important nutrient source from the water column. Additionally, the faster sinking rate decreased the dispersion of the feces causing accumulation of feces and plastic particles near where the animals are settled. This accumulation can increase carbon and nitrogen levels on the seafloor and trigger algal blooms, representing another critical impact of microplastics on the balance of the marine food web”.

 

The researchers conclude: “In this study, we uncovered significant aspects of the influence of filter-feeding animals on the characteristics of microplastic particles in their environment and within the marine food web. The most alarming conclusion is that the microplastic problem is far more complex than initially thought. Plastic pollution in the marine environment has many unexpected dimensions, and its complexities continue to grow. Sometimes, neither we nor the environment can even recognize it as plastic. As time goes on, plastic continues to harm more and more marine ecosystems. We must develop new technologies to mitigate this dangerous phenomenon”.

Research

Feb 9th, 2025
First of Its Kind: mRNA Drugs Delivered Straight to the Gut

Potential new therapy for Crohn’s, colitis, and other inflammatory diseases.

  • Medicine

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system of the small and large intestines — bypassing the liver upon systemic administration. By simply altering the composition of the nanoparticles, the researchers demonstrated that mRNA-based drugs can be directed straight to target cells, avoiding the liver.

 

The groundbreaking Tel Aviv University study was led by post-doctoral fellow Dr. Riccardo Rampado together with Vice President for R&D Prof. Dan Peer, a pioneer in the development of mRNA therapeutics and Director of the Laboratory of Precision Nano-Medicine at the Shmunis School of Biomedicine and Cancer Research. The study was published on the cover of the prestigious journal Advanced Science.

 

Prof. Dan Peer.

 

Targeting Drugs More Precisely with Lipid Nanoparticles

"Everything injected into the bloodstream eventually ends up in the liver — that's just how our anatomy works", explains Prof. Peer. "This poses two challenges. First, drugs intended to target specific cells in particular organs may be toxic to the liver. Second, we don’t want drugs to get 'stuck' in the liver. Ideally, the drug would reach the target organ first, and any remnants would then break down in the liver. We discovered that altering the proportions of lipids comprising the nanoparticles determines their destination in the bloodstream. This is a general phenomenon, meaning it works regardless of the specific lipids, which makes this a significant breakthrough".

 

To demonstrate the concept, Prof. Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA, encapsulated it in lipid nanoparticles with a composition different from those typically used (such as in mRNA COVID-19 vaccines), and successfully delivered it to the intestines of animal models with Crohn's disease and colitis via intravenous injection.

 

"Not only were we able to deliver an mRNA-based anti-inflammatory drug directly to the inflamed intestine and improve all markers of colitis and Crohn's disease, but we also transformed the immune cells in the intestine into factories for producing the anti-inflammatory interleukin-10", Prof. Peer explains. "But this is just a proof of concept study. By tweaking the nanoparticle composition, we could deliver other RNA-based drugs to different organs. There's a saying in American English: 'It’s all in the formulation'. That’s exactly what this is about".

 

Higher Phospholipids, Faster Delivery

In general, lipid-based drugs are encased in synthetic lipid nanoparticles, which mimic biological membranes. One of these lipids is phospholipid named phosphatidylcholine, a component found in all biological membranes. In vaccines like the COVID-19 vaccine, the mRNA is encapsulated in lipid particles containing about 10% of this phospholipid. Prof. Peer and his team increased the phospholipid ratio to 30% and demonstrated that this adjustment caused the particles to float through the bloodstream like oil on water.

 

"That’s the whole trick", Prof. Peer concludes. "We adjusted the lipid composition and found that at 30% phospholipid, the drug is directed straight to the intestine. Of course, this wasn't a blind trial-and-error approach. We understand the mechanism, at least partially, and recognize that this ratio more closely resembles a natural biological membrane, which intestinal cells are better suited to absorb. Now, we are exploring further adjustments to target the pancreas and other organs that can only be reached by fine-tuning the lipid nanoparticle composition. This direct delivery method for mRNA drugs opens up broad possibilities for developing new and more precise therapies than ever before".

Research

Feb 9th, 2025
Innovative Technology from TAU researchers can double IVF Success Rates

New tech enhances sperm selection, boosting IVF success.

  • Biology
  • Engineering

 

A new technology developed at Tel Aviv University and implemented at Barzilai Medical Center in Ashkelon has demonstrated a significant increase in the success rates of fertilization, pregnancy, and the birth of a healthy baby through in vitro fertilization (IVF). According to the findings collected thus far, the technology has increased IVF success rates from 34% to 65% — resulting in 20 pregnancies out of 31 embryo transfers compared to only 14 pregnancies out of 41 embryo transfers in the control group. Among the notable cases was a couple who, after enduring 15 unsuccessful IVF cycles over several years, conceived for the first time using this technology and finally became parents. The research team highlights that this method enables laboratories to select high-quality sperm cells (as defined by the World Health Organization) for fertilization, dramatically improving the likelihood of pregnancy and the birth of a healthy baby.

 

The groundbreaking technology was developed in the lab of Prof. Natan T. Shaked, Chair of the Department of Biomedical Engineering, Fleischman Faculty of Engineering at Tel Aviv University, and is being implemented through QART Medical, a startup company established with the support of the university’s investment fund, its technology transfer company, Ramot, as well as external investors. The method has been published in leading journals, including PNAS, Advanced Science, and Fertility and Sterility. In addition to Barzilai Hospital in Ashkelon, the technology has recently been implemented in clinical research at Meir Medical Center in Kfar Saba, Assuta Medical Center in Ramat HaHayal, HaEmek Medical Center in Afula, and Galilee Medical Center in Nahariya. It is also used at two leading international medical institutions: UCSF Medical Center in California and the University of Tokyo Hospital in Japan. To date, dozens of couples have enrolled in clinical trials.

 

Fertility Challenges: Declining Sperm Counts and IVF Solutions

Dr. Bozhena Saar-Ryss, Director of the IVF Unit and the Sperm Bank at Barzilai Medical Center, explains: “Fertility issues are becoming increasingly critical: one in six couples faces fertility problems, with male-related issues accounting for half of the cases. Additionally, in certain countries like Japan, Korea, and Spain, dramatic declines in birth rates are leading to population shrinkage. The causes for this are diverse and include societal trends like career prioritization and delayed marriages, as well as health issues potentially caused by environmental pollutants. Over the past few decades, sperm counts in young, healthy men have dropped by approximately 50%. One of the major challenges in IVF is selecting a sperm cell with high-quality structure and motility to inject into the egg, which enables the development of a healthy embryo”. The clinical study at Brazilai Medical Center was led by the embryologist Dr. Yulia Michailov, the Director of the IVF unit and the sperm lab at Brazilai.

 

Prof. Natan T. Shaked, Chair of the Department of Biomedical Engineering at Tel Aviv University, explains the technology: “Biological cells are transparent, making it necessary to use chemical dyes to examine their internal structure for research or fertility diagnostic purposes. These dyes enable the analysis and measurement of the cell’s internal structure under conventional microscopes. However, when it comes to IVF, using dyes on sperm cells is prohibited, as the dye may penetrate the embryo’s DNA and cause damage. Currently, because embryologists rely on subjective assessments of sperm cells based on their external appearance and motility, about 90% of sperm cells that appear suitable to embryologists fail to meet the internal morphological criteria recommended by the World Health Organization (WHO). Live birth rates in IVF are only 15–25%, and many couples undergo over five treatment cycles before achieving pregnancy”.

 

Prof. Natan T. Shaked

 

Is 3D Imaging the Future of Sperm Selection for IVF?

Prof. Shaked adds: “Our technology provides embryologists with a new and essential tool to identify sperm cells that meet the WHO criteria for IVF labs. This new method provides three-dimensional imaging and visualization of the internal structure of biological cells without chemical staining, as it is based on the light-conducting properties of the cell contents, known as the refractive index. This method allows embryologists to analyze the internal structure and contents of live sperm cells and even measure new parameters like mass and volume. Embryologists can therefore select sperm cells that meet the WHO’s structural criteria, achieving results comparable to chemical staining for live cells in the first time. This significantly increases the chances of successful fertilization, pregnancy, and the birth of a healthy baby, as demonstrated by the clinical trial results”.

 

Dr. Ronen Kreizman, CEO of Ramot: “Ramot congratulates Prof. Shaked and his team, as well as QART Medical, on their remarkable achievements. Successes like this are a testament to the immense potential of inventions originating from Tel Aviv University. Ramot takes great pride in playing an active role in establishing innovative companies like QART Medical, which implement the groundbreaking technologies developed at Tel Aviv University. We believe that the model of creating companies around research technologies makes a significant contribution both to the economy and to humanity”.

 

Currently, Prof. Shaked’s team is developing a new method to detect DNA fragmentation in sperm cells, which will be integrated into the new technology. Prof. Shaked: “Our goal is to provide embryologists with a technology that enables individual sperm selection based on three essential criteria: motility, internal structure, and unfragmented DNA. This will allow embryologists to select the best sperm cell for fertilization and dramatically improve success rates in this vital procedure.

 

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained
here and / or the use of such content is in your opinion infringing Contact us as soon as possible >>